515 related articles for article (PubMed ID: 28366477)
1. Biologic Therapies for Autoimmune and Connective Tissue Diseases.
Wolfe RM; Ang DC
Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477
[TBL] [Abstract][Full Text] [Related]
2. [Lung and autoimmune disease--therapy].
Hauber HP; Zabel P
Dtsch Med Wochenschr; 2007 Aug; 132(33):1703-6. PubMed ID: 17713868
[TBL] [Abstract][Full Text] [Related]
3. [Biological therapy of arthritis and systemic autoimmune diseases].
Tamási L; Szekanecz Z
Orv Hetil; 2007 Apr; 148 Suppl 1():63-70. PubMed ID: 17430797
[TBL] [Abstract][Full Text] [Related]
4. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
Sfikakis PP
Curr Dir Autoimmun; 2010; 11():180-210. PubMed ID: 20173395
[TBL] [Abstract][Full Text] [Related]
5. Update on the role of Interleukin 17 in rheumatologic autoimmune diseases.
Konya C; Paz Z; Apostolidis SA; Tsokos GC
Cytokine; 2015 Oct; 75(2):207-15. PubMed ID: 26028353
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin therapy for rheumatic diseases.
Sany J
Curr Opin Rheumatol; 1994 May; 6(3):305-10. PubMed ID: 8060767
[TBL] [Abstract][Full Text] [Related]
7. Expanding possibilities in the treatment of patient groups with previously difficult-to-treat patients.
Dörner T; Burmester GR
Curr Opin Rheumatol; 2010 May; 22(3):235-6. PubMed ID: 20351494
[No Abstract] [Full Text] [Related]
8. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
Guzman Moreno R
Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
[TBL] [Abstract][Full Text] [Related]
9. Biologics in the treatment of rheumatoid arthritis and ankylosing spondylitis.
Braun J; Kalden JR
Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S164-7. PubMed ID: 19822066
[TBL] [Abstract][Full Text] [Related]
10. Advances in rheumatology: new targeted therapeutics.
Tak PP; Kalden JR
Arthritis Res Ther; 2011 May; 13 Suppl 1(Suppl 1):S5. PubMed ID: 21624184
[TBL] [Abstract][Full Text] [Related]
11. The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?
Kato M; Yasuda S; Atsumi T
Rheumatol Int; 2018 Aug; 38(8):1333-1338. PubMed ID: 29623390
[TBL] [Abstract][Full Text] [Related]
12. New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy.
Braun J; de Keyser F; Brandt J; Mielants H; Sieper J; Veys E
Curr Opin Rheumatol; 2001 Jul; 13(4):245-9. PubMed ID: 11555723
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies in the connective tissue diseases: their relation to the antiphospholipid syndrome and forme fruste disease.
Buchanan RR; Wardlaw JR; Riglar AG; Littlejohn GO; Miller MH
J Rheumatol; 1989 Jun; 16(6):757-61. PubMed ID: 2778757
[TBL] [Abstract][Full Text] [Related]
14. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
[TBL] [Abstract][Full Text] [Related]
15. Secukinumab for rheumatology: development and its potential place in therapy.
Koenders MI; van den Berg WB
Drug Des Devel Ther; 2016; 10():2069-80. PubMed ID: 27445458
[TBL] [Abstract][Full Text] [Related]
16. Brief Report: Patterns and Secular Trends in Use of Immunomodulatory Agents During Pregnancy in Women With Rheumatic Conditions.
Desai RJ; Huybrechts KF; Bateman BT; Hernandez-Diaz S; Mogun H; Gopalakrishnan C; Patorno E; Kim SC
Arthritis Rheumatol; 2016 May; 68(5):1183-9. PubMed ID: 26606742
[TBL] [Abstract][Full Text] [Related]
17. Musculoskeletal manifestations and autoimmune diseases related to new biologic agents.
Haraoui B; Keystone E
Curr Opin Rheumatol; 2006 Jan; 18(1):96-100. PubMed ID: 16344625
[TBL] [Abstract][Full Text] [Related]
18. [Rheumatic diseases in pregnancy].
Märker-Hermann E; Bauer H; Gromnica-Ihle E
Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte transformation to connective tissue antigens in adult and juvenile rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, systemic lupus erythematosus, and a nonarthritic control population.
Golds EE; Stephen IB; Esdaile JM; Strawczynski H; Poole AR
Cell Immunol; 1983 Nov; 82(1):196-209. PubMed ID: 6640674
[TBL] [Abstract][Full Text] [Related]
20. Biological therapies of autoimmune diseases.
Kourbeti IS; Boumpas DT
Curr Drug Targets Inflamm Allergy; 2005 Feb; 4(1):41-6. PubMed ID: 15720235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
